av/erytech-pharma--big.svg

COM:ERYTECH

PHAXIAM Therapeutics

  • Stock

Last Close

0.80

28/06 15:35

Market Cap

48.66M

Beta: -

Volume Today

27.49K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Sep '18
Dec '18
Mar '19
Jun '19
Sep '19
Dec '19
Sep '20
Dec '20
Mar '21
Jun '21
Dec '21
Mar '22
Jun '22
Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
Jun '24
revenue
139K
-
546.50K
-
546.50K
0%
cost of revenue
8.97M
-
7.74M
13.74%
14.26M
-
15.22M
6.72%
10.51M
-
2.88M
-
261K
-
469K
-
370K
-
gross profit
-8.97M
-
-7.74M
13.74%
-14.26M
-
-15.22M
6.72%
-10.51M
-
-2.88M
-
139K
-
-261K
287.77%
-469K
-
546.50K
216.52%
176.50K
67.70%
selling and marketing expenses
general and administrative expenses
3.08M
-
4.47M
45.35%
4.85M
8.41%
4.79M
1.16%
3.52M
26.59%
3.26M
7.31%
3.42M
4.79%
2.84M
16.98%
4.17M
47.14%
3.52M
15.62%
4.94M
-
2.14M
56.72%
3.79M
77.59%
3.02M
20.50%
2.92M
3.35%
2.96M
-
2.67M
-
2.67M
0%
selling general and administrative expenses
3.08M
-
4.47M
45.35%
4.85M
8.41%
4.79M
1.16%
3.52M
26.59%
3.26M
7.31%
3.42M
4.79%
2.84M
16.98%
4.17M
47.14%
3.52M
15.62%
7.41M
110.37%
4.94M
33.33%
2.14M
56.72%
3.79M
77.59%
3.02M
20.50%
2.92M
3.35%
9.13M
213.27%
2.96M
67.59%
4.83M
63.15%
2.67M
44.68%
2.67M
0%
research and development expenses
9.17M
-
19.17M
-
8.12M
57.66%
9.18M
13.16%
3.08M
66.50%
-470K
115.27%
1.72M
465.00%
3.28M
91.20%
3.33M
1.37%
7.01M
110.83%
3.20M
54.31%
3.20M
0%
other expenses
-303K
-
-2.22M
632.34%
-757K
65.89%
-10.53M
1,290.62%
-1.18M
88.78%
-1.24M
5.08%
41.56M
3,448.75%
-43.08M
203.67%
-1.44M
96.66%
22.71M
1,677.22%
-539K
-
422K
178.29%
-1.31M
409.48%
-5.22M
300%
cost and expenses
11.75M
-
9.99M
14.93%
13.26M
32.72%
16.98M
28.04%
16.59M
2.28%
17.23M
3.86%
16.13M
6.42%
17.33M
7.47%
13.24M
23.59%
15.72M
18.69%
29.46M
87.39%
12.52M
57.52%
11.74M
6.17%
5.57M
52.60%
-2.68M
148.10%
6.38M
338.23%
12.68M
98.76%
5.76M
54.58%
12.31M
113.83%
5.88M
52.27%
5.88M
0%
operating expenses
2.77M
-
2.25M
18.79%
13.26M
488.94%
-5.74M
143.25%
2.34M
140.73%
2.02M
13.57%
44.97M
2,127.54%
-40.25M
189.49%
2.73M
106.79%
26.23M
859.86%
26.57M
1.30%
12.52M
52.91%
11.74M
6.17%
5.57M
52.60%
-2.68M
148.10%
6.38M
338.23%
12.41M
94.67%
5.76M
53.63%
11.84M
105.68%
5.88M
50.38%
5.88M
0%
interest expense
2K
-
1K
50%
64K
6,300%
217K
239.06%
105K
51.61%
106K
0.95%
2.39M
2,157.55%
-463K
119.35%
747K
261.34%
486K
34.94%
911K
87.45%
236K
74.09%
34K
85.59%
611K
1,697.06%
483K
20.95%
103K
-
314K
204.85%
93K
70.38%
ebitda
-10.52M
-
-8.40M
20.15%
-11.60M
38.06%
-17.40M
50.03%
-12.96M
25.54%
-17.08M
31.83%
-16.20M
5.20%
-20.21M
24.78%
-11.20M
44.59%
-15.52M
38.59%
-26.57M
71.24%
-11.68M
56.07%
14.66M
225.55%
-1.56M
110.62%
3.10M
299.04%
-3.95M
227.42%
-12.41M
214.40%
-5.49M
55.81%
-11.84M
115.84%
-5.28M
55.41%
-5.28M
0%
operating income
-11.75M
-
-9.99M
14.93%
-13.26M
32.72%
-16.98M
28.04%
-16.59M
2.28%
-17.23M
3.86%
-16.13M
6.42%
-17.33M
7.47%
-13.24M
23.59%
-15.72M
18.69%
-29.46M
87.39%
-12.52M
57.52%
12.61M
200.74%
-5.57M
144.15%
2.68M
148.10%
-4.49M
267.76%
-12.68M
182.16%
-5.75M
54.65%
-12.31M
114.12%
-5.33M
56.71%
-5.33M
0%
depreciation and amortization
168K
-
171K
1.79%
1.66M
872.51%
-422K
125.38%
908K
315.17%
2.21M
143.72%
-67K
103.03%
-2.88M
4,191.04%
2.05M
171.20%
202K
90.13%
2.88M
1,328.22%
840K
70.88%
2.05M
144.05%
4.01M
95.61%
421K
89.50%
543.75K
29.16%
261K
52%
263K
0.77%
469K
78.33%
49.50K
89.45%
49.50K
0%
total other income expenses net
1.05M
-
1.42M
34.50%
1.60M
12.68%
-639K
139.96%
2.62M
510.49%
-2.17M
182.69%
-2.46M
13.42%
-2.41M
1.95%
1.30M
153.90%
-284K
121.85%
2.08M
831.34%
604K
70.92%
2.02M
233.77%
531K
73.66%
-62K
111.68%
-1.71M
2,661.29%
24K
101.40%
111K
362.50%
228K
105.41%
21.50K
90.57%
21.50K
0%
income before tax
-10.69M
-
-8.57M
19.81%
-11.66M
36.04%
-17.62M
51.07%
-13.97M
20.71%
-19.40M
38.89%
-18.59M
4.20%
-19.75M
6.22%
-11.95M
39.51%
-16.00M
33.99%
-27.38M
71.08%
-11.91M
56.50%
14.62M
222.78%
-5.04M
134.44%
2.62M
151.95%
-6.20M
337.18%
-12.65M
103.92%
-5.69M
55.03%
-12.08M
112.37%
-5.31M
56.07%
-5.31M
0%
income tax expense
-13K
-
1K
107.69%
1K
-
-2K
300%
-2.06M
103,050%
2K
100.10%
1K
50%
2K
-
-1.54M
76,950%
-840K
45.35%
3.74M
544.88%
102K
97.27%
-3.32M
3,352.94%
104K
103.13%
-451K
533.65%
52K
111.53%
-795K
1,628.85%
10K
101.26%
10K
0%
net income
-10.68M
-
-8.57M
19.70%
-11.66M
36.02%
-17.62M
51.08%
-13.97M
20.72%
-19.40M
38.89%
-18.59M
4.18%
-19.75M
6.22%
-11.95M
39.51%
-16.01M
34.01%
-25.84M
61.46%
-11.07M
57.16%
10.89M
198.34%
-5.14M
147.19%
5.94M
215.53%
-6.10M
202.77%
-12.20M
100%
-5.69M
53.36%
-11.29M
98.37%
-5.32M
52.89%
-5.32M
0%
weighted average shs out
17.94M
-
17.94M
0%
17.94M
0%
17.94M
0%
17.94M
0%
17.94M
0%
17.94M
0%
17.94M
0%
21.62M
20.51%
21.62M
0%
3.36M
84.48%
31.02M
824.24%
31.02M
0%
31.02M
0%
31.02M
0%
3.28M
89.41%
355.37K
89.18%
6.57M
-
5.38M
18.07%
6.07M
12.81%
weighted average shs out dil
17.94M
-
17.94M
0%
17.94M
0%
17.94M
0%
17.94M
0%
17.94M
0%
17.94M
0%
17.94M
0%
21.62M
20.51%
21.62M
0%
3.36M
84.48%
31.02M
824.24%
31.02M
0%
31.02M
0%
31.02M
0%
3.28M
89.41%
355.37K
89.18%
6.57M
-
5.38M
18.07%
6.07M
12.81%
eps
-0.60
-
-0.48
20%
-0.65
35.42%
-0.98
50.77%
-0.78
20.41%
-1.08
38.46%
-1.04
3.70%
-1.10
5.77%
-0.55
50%
-0.74
34.55%
-7.70
940.54%
-0.36
95.32%
0.35
197.22%
-0.17
148.57%
0.19
211.76%
-1.86
1,078.95%
-34.33
1,745.70%
0
100%
-1.72
Infinity%
-0.99
42.62%
-0.88
10.84%
epsdiluted
-0.60
-
-0.48
20%
-0.65
35.42%
-0.98
50.77%
-0.78
20.41%
-1.08
38.46%
-1.04
3.70%
-1.10
5.77%
-0.55
50%
-0.74
34.55%
-7.70
940.54%
-0.36
95.32%
0.35
197.22%
-0.17
148.57%
0.19
211.76%
-1.86
1,078.95%
-34.33
1,745.70%
0
100%
-1.72
Infinity%
-0.99
42.62%
-0.88
10.84%

All numbers in (except ratios and percentages)